Iammatteo Melissa, Keskin Taha, Jerschow Elina
Division of Allergy and Immunology, Department of Medicine, Montefiore Medical Center, Albert Einstein College of Medicine, Bronx, New York.
Division of Allergy and Immunology, Department of Medicine, Montefiore Medical Center, Albert Einstein College of Medicine, Bronx, New York.
Ann Allergy Asthma Immunol. 2017 Oct;119(4):349-355.e2. doi: 10.1016/j.anai.2017.07.013. Epub 2017 Aug 31.
Identifying the cause of periprocedural hypersensitivity reactions (HSRs) remains challenging because of the multitude of medications involved. Antibiotics are the most common cause in the United States, whereas neuromuscular blocking agents are most common in Europe.
To identify causative agents for periprocedural HSRs.
This study was a 7-year retrospective medical record review of patients evaluated between December 2009 and January 2017 at a drug allergy center in Bronx, New York for periprocedural HSRs, defined as occurring soon before, during, or soon after a medical procedure or operation with or without general anesthesia. Demographics, description of historical HSRs, results of testing to potential causative medications, and tolerance of subsequent anesthesia were reviewed.
Thirty-four patients completed a comprehensive evaluation. Skin testing identified an IgE-mediated cause in 22 patients (64.7%). The most common causative class of medications was induction agents (n = 9 [36%]), with midazolam being the most frequently implicated (n = 6 [3 positive skin test results, 3 equivocal skin test results]). Cefazolin was the most common agent identified (n = 8 [32%]) followed by ondansetron (n = 3 [12%]). Sixteen of 22 contacted patients were exposed to subsequent anesthesia, including 3 patients with negative evaluations. One patient experienced a mild urticarial HSR.
Induction agents were the most common causative agents in our patients, which differs from other studies. Given the variability in evaluations of periprocedural HSRs across the United States with data published on small sample sizes, there is a need to establish national guidelines to standardize evaluations and to create a national registry to allow for data sharing.
由于涉及的药物种类繁多,确定围手术期过敏反应(HSR)的原因仍然具有挑战性。在美国,抗生素是最常见的原因,而在欧洲,神经肌肉阻滞剂最为常见。
确定围手术期HSR的致病因素。
本研究是一项为期7年的回顾性病历审查,研究对象为2009年12月至2017年1月在纽约布朗克斯区一家药物过敏中心接受围手术期HSR评估的患者,围手术期HSR定义为在有或无全身麻醉的医疗程序或手术之前、期间或之后不久发生的过敏反应。回顾了患者的人口统计学资料、既往HSR的描述、对潜在致病药物的检测结果以及后续麻醉的耐受性。
34例患者完成了全面评估。皮肤试验确定22例患者(64.7%)的过敏反应由IgE介导。最常见的致病药物类别是诱导剂(n = 9 [36%]),其中咪达唑仑最常被提及(n = 6 [3例皮肤试验结果阳性,3例皮肤试验结果不明确])。头孢唑林是最常见的确定致病药物(n = 8 [32%]),其次是昂丹司琼(n = 3 [12%])。22例接受联系的患者中有16例接受了后续麻醉,其中3例评估结果为阴性。1例患者出现轻度荨麻疹性HSR。
诱导剂是我们研究中患者最常见的致病因素,这与其他研究不同。鉴于美国各地对围手术期HSR的评估存在差异,且发表的数据样本量较小,因此需要制定国家指南以规范评估,并建立国家登记册以实现数据共享。